
Pfenex to Announce Third Quarter 2019 Financial Results on November 7th
SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX), a development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to develop and improve protein therapies for unmet patient needs, …